Prognosis of patients with small cell lung cancer with or without interstitial pneumonia treated with postoperative adjuvant chemotherapy: A retrospective study
Not Applicable
- Conditions
- Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000051612
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient who received chemoradiotherapy as postoperative treatment. 2. Patient who had not been treated with postoperative adjuvant chemotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The 3-year overall survival rate
- Secondary Outcome Measures
Name Time Method 3-year disease-free survival rate, overall survival, disease-free survival, frequency of adverse events, frequency and severity of treatment-related acute exacerbations of interstitial pneumonia.